Operations Excellence: Perfecting IT Management System Selection for Biopharmaceutical Organizations - Proper application of an IT system can be a critical component to driving efficiency and reducing

ADVERTISEMENT

Operations Excellence: Perfecting IT Management System Selection for Biopharmaceutical Organizations
Proper application of an IT system can be a critical component to driving efficiency and reducing waste


BioPharm International
Volume 19, Issue 6

Highly efficient companies use IT extensively, and with great success. However, the need and resulting form of the IT system were determined through systematic root cause analysis, that determined its use was the only way to drive better and more consistent performance. As companies reach for Six Sigma performance, humans involved in the process become too variable and error prone.

Additionally, information needs to be viewed, analyzed, and reacted to in real-time. Within biopharma, the most exciting waste reducing technology is process analytical technology. Can you imagine a plant with no quality control laboratories (and no laboratory information management system?) Until then, biopharma should concentrate on solving real problems that cause inefficiencies, making the difficult choices around removing waste, and minimizing the footprint of IT on the organization.

OPERATIONS EXCELLENCE CONSORTIUM

The complete schedule for future meetings of the Operations Excellence Consortium will be available soon. The next West Coast meeting is scheduled for July 20, hosted by Bayer in Berkeley, CA. Please refer to http://www.Tefen.com/bio/ for additional information.

Marc Punch is a partner at Tefen,Lt.,1065 E. Hillsdale Blvd., Suite 1615, Foster City, CA 94404; tell 650.357.1120 X117 (Office) 415.290.4580 (mobile), fax 650.372.1350,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here